Literature DB >> 1769811

Period prevalence of allergic bronchopulmonary mycosis in a regional hospital outpatient population in Ireland 1985-88.

S C Donnelly1, H McLaughlin, C P Bredin.   

Abstract

The period of prevalence, 1988 inclusive, of Allergic Bronchopulmonary Aspergillosis (ABPA) and Allergic Bronchopulmonary Candiasis (ABPC), the two most frequently reported forms of allergic Bronchopulmonary Mycosis (ABPM), was investigated in an Irish regional hospital respiratory medicine outpatients, catchment area population 536,000. ABPM was defined by the presence of a majority of seven criteria: asthma, eosinophilia, elevated IgE, antibodies to Aspergillus Fumigatus or Candida Albicans, immediate skin test reaction to either fungus, culture of either fungus in sputum, and otherwise unexplained transient or permanent lung field x-ray abnormalities. New referrals were investigated for ABPM if they had asthma and eosinophilia, or asthma and lung field x-ray abnormalities. Fourteen patients with ABPM were identified from a total of 1390 new referrals, a period prevalence of just over one per cent. It is concluded that (1) ABPM is a relatively common disorder in an Irish regional hospital respiratory medicine outpatient population and (2) ABPC constitutes a higher proportion of this disorder than previously considered.

Entities:  

Mesh:

Year:  1991        PMID: 1769811     DOI: 10.1007/bf02948415

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  17 in total

1.  Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings.

Authors:  J L Malo; R Hawkins; J Pepys
Journal:  Thorax       Date:  1977-06       Impact factor: 9.139

2.  Candida albicans precipitins in respiratory disease in man.

Authors:  J Pepys; J A Faux; D S McCarthy; F E Hargreave
Journal:  J Allergy       Date:  1968-06

3.  Measurement of IgE in normal and allergic serum by radioimmunoassay.

Authors:  G J Gleich; A K Averbeck; H A Swedlund
Journal:  J Lab Clin Med       Date:  1971-04

4.  Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests.

Authors:  A H Henderson; M P English; R J Vecht
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

5.  Role of Aspergillus and Candida species in allergic bronchopulmonary mycoses. A comparative study.

Authors:  R S Sandhu; S K Mehta; Z U Khan; M M Singh
Journal:  Scand J Respir Dis       Date:  1979-10

6.  Allergic bronchopulmonary curvulariosis.

Authors:  J M Halwig; D A Brueske; P A Greenberger; R B Dreisin; H M Sommers
Journal:  Am Rev Respir Dis       Date:  1985-07

7.  Allergic bronchopulmonary candidiasis.

Authors:  K Akiyama; D A Mathison; J B Riker; P A Greenberger; R Patterson
Journal:  Chest       Date:  1984-05       Impact factor: 9.410

8.  Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis.

Authors:  R McAleer; D B Kroenert; J L Elder; J H Froudist
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

9.  Late sequelae of allergic bronchopulmonary aspergillosis.

Authors:  P A Greenberger; R Patterson; A Ghory; J A Arkins; T Walsh; T Graves; J Saker
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

10.  Bronchopulmonary torulopsosis.

Authors:  R Patterson; B S Samuels; J J Phair; M Roberts
Journal:  Int Arch Allergy Appl Immunol       Date:  1982
View more
  3 in total

1.  Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis.

Authors:  E Harrison; A Singh; J Morris; N L Smith; M G Fraczek; C B Moore; D W Denning
Journal:  Int J Immunogenet       Date:  2012-01-09       Impact factor: 1.466

Review 2.  Burden and distinctive character of allergic bronchopulmonary aspergillosis in India.

Authors:  Ritesh Agarwal
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

3.  Identifying rare diseases using electronic medical records: the example of allergic bronchopulmonary aspergillosis.

Authors:  Andrew Maguire; Michelle E Johnson; David W Denning; Germano L C Ferreira; Adrian Cassidy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03-31       Impact factor: 2.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.